...
首页> 外文期刊>Gut and Liver >Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
【24h】

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis

机译:溃疡性结肠炎患者末端肠炎症的预后价值

获取原文
           

摘要

Background/Aims: Few studies have investigated terminal ileal lesions and their prognostic value in patients with ulcerative colitis (UC). We evaluated the clinical significance of these le- sions as a prognostic factor in patients with UC who were in clinical remission. Methods: We retrospectively selected 567 of 4,066 colonoscopy reports that included positive findings from orificial observations of the terminal ileum (TI) and appendix in patients with UC. We finally recruited patients who were in clinical remission (n=204). We compared the clinical cours- es, including relapse and other prognostic parameters associated with UC, between the groups. Results: The baseline patient characteristics were not significantly different between patients with (n=69, TI+ group) and without TI lesions (n=135, TI– group), although there were more never-smokers in the TI+ group (n=57 [82.6%] in the TI+ group; n=86 [63.7%] in the TI– group; p=0.005). Of note, appendiceal orifice inflammation (AOI) was less frequently found in the TI+ group (14.5%) than in the TI– group (71.9%, p<0.001). The cumulative relapse rate was numeri- cally higher in the TI– group, but it was not significantly different according to the Kaplan-Meier analysis (p=0.116). Multivariate Cox regression analysis also revealed advanced age at diagno- sis as the most significant factor (adjusted hazard ratio, 0.964; 95% confidence interval, 0.932 to 0.998; p=0.037), but neither TI inflammation nor AOI were significantly associated with the cumulative relapse rate in patients with UC in clinical remission. Conclusions: For patients with UC in clinical remission, neither terminal ileal lesions nor AOI had significant clinical or predictive value for future relapse.
机译:背景/目的:少数研究已经研究了溃疡性结肠炎(UC)患者的末端髂骨病变及其预后价值。我们评估了这些界面作为临床缓解患者患者的预后因素的临床意义。方法:我们回顾性地选择了4,066个结肠镜检查的567个报告,其中包括UC患者末端(TI)和附录中的人工观察结果。我们终于招募了临床缓解的患者(n = 204)。我们比较了临床课程,包括复发和与UC相关的其他预后参数,在组之间。结果:(n = 69,Ti +组)和没有Ti病变(n = 135,Ti-group)之间的基线患者特征在没有显着差异(n = 135,Ti-group),但是在Ti +组中还有更多来自吸烟者(n = 57 [82.6%]在Ti +基团中;在Ti-group中n = 86 [63.7%]; p = 0.005)。注意,在Ti +基团(14.5%)中,阑尾孔炎症(AOI)比Ti-Group(71.9%,P <0.001)较少。累积复发率在Ti-Group中具有数值较高,但根据Kaplan-Meier分析(P = 0.116)没有显着差异。多元COX回归分析还揭示了诊断时的晚期,作为最重要的因素(调整后危险比,0.964; 95%置信区间,0.932至0.998; P = 0.037),但Ti炎症和AOI都没有与累积显着相关临床缓解患者患者的复发率。结论:对于UC在临床缓解中的患者,末端肠梗阻和AOI都没有显着的临床或预测值,以便复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号